Personal information
Biography
Adam Northcutt, Ph.D. joined Canopy Biosciences in 2019 and is the US Manager of ChipCytometry where he is responsible for overseeing all US-based services and R&D related to the ChipCytometry technology. Adam received his Ph.D in Biology from the University of Missouri-Columbia where he worked to examine the molecular basis of neuronal cell identity and generate novel bioinformatic resources for model organisms of traditional electrophysiology. In his Post Doc in the lab of David Schulz, he focused on altering neuronal phenotypes through mRNA injections that disrupted balanced expression profiles.